Epcoritamab, a CD3 x CD20 Bispecific Antibody, Plus R2 in R/R Follicular Lymphoma: Updated Analysis of Phase I/II EPCORE NHL-2 Trial

June 3-7, 2022; Chicago, Illinois
In this updated analysis of the cohort with relapsed/refractory follicular lymphoma enrolled on an ongoing phase I/II trial, epcoritamab in combination with rituximab and lenalidomide was associated with a manageable safety profile and an ORR of 100%.
Format: Microsoft PowerPoint (.ppt)
File Size: 135 KB
Released: June 16, 2022

Acknowledgements

Provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by educational grants from
AbbVie
AstraZeneca
Gilead Sciences, Inc.
Merck Sharp & Dohme Corp.
Novartis Pharmaceuticals Corporation
Seattle Genetics

Related Content

Expert faculty answer audience questions from a live satellite symposium presented at ASCO 2022 on the management of MDS, from Clinical Care Options (CCO)

Rami S. Komrokji, MD
Program Director
Amy E. DeZern, MD, MHS Amer Zeidan, MBBS, MPH
Released: August 9, 2022

Commentary on the evolving therapeutic landscape in peripheral T-cell lymphomas with a focus on EZH1/2 inhibition, from Clinical Care Options (CCO)

Steven M. Horwitz, MD
Program Director
Pamela B. Allen, MD Pierluigi Porcu, MD
Released: August 8, 2022

Video featuring Jesús Berdeja, MD, and Sagar Lonial, MD, discussing the latest evidence on approved and investigational CAR T-cell therapies for multiple myeloma, from Clinical Care Options (CCO)

Jesús G. Berdeja, MD Sagar Lonial, MD Physicians: maximum of 1.0 AMA PRA Category 1 Credit Released: August 5, 2022 Expired: August 4, 2023

Expert webcast recording of live webinar on selecting therapy and managing toxicities for indolent B-cell lymphomas, from Clinical Care Options (CCO)

Elizabeth Brém, MD
Program Director
Christopher R. Flowers, MD, MS
Program Director
person default Pallawi Torka, MD
Physicians: maximum of 1.0 AMA PRA Category 1 Credit Registered Nurses: 1.0 Nursing contact hour Pharmacists: 1.0 contact hour (0.1 CEUs) Released: August 3, 2022 Expired: August 2, 2023

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings